Li Dongjie, Li Xiucheng, Peng Emin, Liao Zhangcheng, Tang Zhengyan
Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan, China; Department of Geriatric urology, Xiangya International Medical Center, Xiangya Hospital, Central South University, Changsha, China; National Clinical Research Center for Geriatric Disorders, Changsha, China.
Department of Urology, Xiangya Hospital, Central South University, Changsha, China.
Sex Med. 2020 Jun;8(2):195-204. doi: 10.1016/j.esxm.2019.12.002. Epub 2020 Jan 30.
Erectile dysfunction (ED) and cardiovascular diseases (CVDs) share many common risk factors. ED could be a strong independent predictive factor of CVDs. Furthermore, the treatment of ED had been shown to be beneficial for cardiovascular diseases. However, the association between ED and CVDs has been reported scarcely in the literature.
To investigate urologists' perception, diagnosis, and treatment of CVDs in patients with ED.
The study was conducted as a prospective study from November 2018 through February 2019, including urologists aged 18-64 years. All participants completed a survey of the knowledge of ED via an online questionnaire platform in 7 WeChat groups of urologists. WeChat is the most popular multipurpose messaging and social media in China.
The main outcomes were the answers that urologists chose or filled.
449 urologists were included. Most of participants (375, 83.5%) agreed that CVDs are associated with ED. Only 231 participants (51.4%) thought ED was an independent disorder. The awareness of the association between ED and CVDs is significantly higher among male urologists than their female counterparts. Although 378 (83.6%) participants believed that the progression of these 2 diseases was consistent, only 181 (44.9%) would do conjoined assessment of both CVDs and ED. In addition, most urologists only considered conventional treatment, such as psychological intervention (341, 75.4%) and phosphodiesterase type 5 inhibitor (PDE5i) therapy (318, 70.4%) for their patients, whereas 339 urologists (88.3%) claimed that they would treat CVDs in patients with both ED and CVDs. 344 (76.6%) urologists showed some concerns over PDE5is.
Urologists' assessment of CVDs in patients with ED was disappointing especially among young and female urologists or those working in underserved areas. Besides, the urologists' treatments of ED were not updated, and their attitudes toward the safety and effectiveness of PDE5is for CVDs were not optimistic. Li D, Li X, Peng A, et al. Do Urologists Really Recognize the Association Between Erectile Dysfunction and Cardiovascular Disease? Sex Med 2020;8:195-204.
勃起功能障碍(ED)和心血管疾病(CVD)有许多共同的危险因素。ED可能是CVD的一个强有力的独立预测因素。此外,已证明ED的治疗对心血管疾病有益。然而,ED与CVD之间的关联在文献中鲜有报道。
调查泌尿外科医生对ED患者心血管疾病的认知、诊断和治疗情况。
本研究为前瞻性研究,时间从2018年11月至2019年2月,纳入年龄在18 - 64岁的泌尿外科医生。所有参与者通过泌尿外科医生的7个微信群中的在线问卷平台完成了一项关于ED知识的调查。微信是中国最受欢迎的多功能通讯和社交媒体。
主要观察指标是泌尿外科医生选择或填写的答案。
共纳入449名泌尿外科医生。大多数参与者(375名,83.5%)同意CVD与ED有关。只有231名参与者(51.4%)认为ED是一种独立的疾病。男性泌尿外科医生对ED与CVD之间关联的认识明显高于女性同行。尽管378名(83.6%)参与者认为这两种疾病的进展是一致的,但只有181名(44.9%)会对CVD和ED进行联合评估。此外,大多数泌尿外科医生仅考虑常规治疗,如心理干预(341名,75.4%)和5型磷酸二酯酶抑制剂(PDE5i)治疗(318名,70.4%)用于他们的患者,而339名泌尿外科医生(88.3%)声称他们会治疗同时患有ED和CVD的患者。344名(76.6%)泌尿外科医生对PDE5i表示了一些担忧。
泌尿外科医生对ED患者心血管疾病的评估令人失望,尤其是在年轻和女性泌尿外科医生或在服务不足地区工作的医生中。此外,泌尿外科医生对ED的治疗没有更新,他们对PDE5i治疗CVD的安全性和有效性的态度也不乐观。李D,李X,彭A等。泌尿外科医生真的认识到勃起功能障碍与心血管疾病之间的关联吗?性医学2020;8:195 - 204。